Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Notified -

‘Hong Kong Summer Viva’: Calling All Fans to Dive into Festivals, Games and Parties – Only in Hong Kong!

Notified -

D328eco® Test Aircraft Rolls Out: A Defining Milestone in Sustainable Regional Aviation

Notified -

YY Group Subsidiary, YY Circle and KFC Singapore Forge Strategic Partnership to Enhance Operational Excellence

Notified -

Falcon Luxe Expands Private Jet Charter Offering with Block Hours Access

Notified -

Bitget Partners with Kronos Research to Deliver Institutional-Grade Liquidity and Trading Efficiency

Notified -

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer

Notified -

‘Unlucky Charm’: Heineken® and Self-Confessed Jinx Go to Extreme Lengths to Protect the Result at 2025 UEFA Champions League Final

Notified -

Copenhagen Infrastructure Partners and PensionDanmark launch microgrid specialist company

Notified -

Constellation Brands to Report First Quarter 2026 Financial Results on July 1, 2025 After Market Close and Host Conference Call on July 2, 2025 at 10:30 AM ET

Notified -

RIB Software Launches Global Customer Campaign: “You See It. Together, We’ll See It Through”

Notified -

Lumi Global Launches Enhanced Pre-Voting Capabilities Across its Digital and Hybrid Meeting and Election Solution

Notified -